The Campbell’s Company (NASDAQ:CPB – Get Free Report) has received an average recommendation of “Reduce” from the twenty-two brokerages that are covering the firm, Marketbeat reports. Six research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $32.2941.
A number of research firms recently commented on CPB. Morgan Stanley dropped their price objective on Campbell’s from $30.00 to $28.00 and set a “cautious” rating on the stock in a report on Friday, January 16th. DA Davidson reissued a “neutral” rating and issued a $30.00 target price on shares of Campbell’s in a research report on Thursday, December 11th. Wells Fargo & Company cut their price target on shares of Campbell’s from $31.00 to $30.00 and set an “equal weight” rating on the stock in a report on Wednesday, December 10th. Barclays set a $27.00 price objective on shares of Campbell’s in a research note on Friday, January 16th. Finally, Royal Bank Of Canada decreased their price objective on shares of Campbell’s from $35.00 to $30.00 and set a “sector perform” rating for the company in a report on Wednesday, December 10th.
Campbell’s Price Performance
Campbell’s (NASDAQ:CPB – Get Free Report) last issued its earnings results on Tuesday, December 9th. The company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.73 by $0.04. Campbell’s had a return on equity of 21.84% and a net margin of 5.69%.The company had revenue of $2.68 billion for the quarter. The firm’s quarterly revenue was down 3.4% on a year-over-year basis. Campbell’s has set its FY 2026 guidance at 2.400-2.550 EPS. Analysts forecast that Campbell’s will post 3.15 EPS for the current fiscal year.
Insider Activity
In other Campbell’s news, EVP Charles A. Brawley III sold 11,550 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an average price of $28.14, for a total transaction of $325,017.00. Following the transaction, the executive vice president owned 43,777 shares in the company, valued at $1,231,884.78. This trade represents a 20.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Anthony Sanzio sold 2,700 shares of Campbell’s stock in a transaction that occurred on Friday, January 9th. The shares were sold at an average price of $26.51, for a total transaction of $71,577.00. Following the completion of the transaction, the executive vice president directly owned 25,264 shares in the company, valued at approximately $669,748.64. This represents a 9.66% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 19.78% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Campbell’s by 3.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,472 shares of the company’s stock worth $777,000 after acquiring an additional 685 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Campbell’s by 4.3% in the first quarter. Goldman Sachs Group Inc. now owns 660,543 shares of the company’s stock worth $26,369,000 after purchasing an additional 27,374 shares during the period. Empowered Funds LLC acquired a new position in shares of Campbell’s during the 1st quarter worth about $446,000. Woodline Partners LP lifted its position in shares of Campbell’s by 40.9% during the 1st quarter. Woodline Partners LP now owns 16,623 shares of the company’s stock worth $664,000 after purchasing an additional 4,827 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in Campbell’s by 333.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company’s stock valued at $39,000 after purchasing an additional 750 shares during the period. 52.35% of the stock is currently owned by institutional investors and hedge funds.
About Campbell’s
Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.
The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.
Recommended Stories
- Five stocks we like better than Campbell’s
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Campbell's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell's and related companies with MarketBeat.com's FREE daily email newsletter.
